Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

This Drugmaker Just Won a First-of-Its-Kind EU Approval, Shares Are Climbing

• Shares trading up 2.27% pre-market, adding $0.67 to reach $30.17, extending Friday's regular-session gain

Nitish Kishor | 24 August 2026

This Biotech Stock Is Rebounding 5% Before the Bell, Here's Why

• Shares trading up 4.54% pre-market, adding $0.23 to reach $5.30, after closing Friday's regular session down 2.12% at $5.07

Nitish Kishor | 24 August 2026

This Penny Stock Is Sinking 15% Before the Bell After Pricing a New Stock Offering

• Shares trading down 15.00% pre-market, losing $0.93 to reach $5.27, reversing Friday's 19.92% regular-session rally

Nitish Kishor | 24 August 2026

EMD Pays $28M Upfront for Werewolf Therapeutics' (NASDAQ: HOWL) Platforms

This arrangement includes an upfront payment of $28 million and a contingent payment of $5 million once the transfer of technology is finalized. This key transaction not only enhances the firm'sLiquiditybut also allows it to focus on activities critical to its clinical objectives.

Vinay Lochav | 21 August 2026

Eaton Stock Initiated as Outperform by Baird Driven by AI Growth

Eaton Corporation has received an outperform rating from Baird, which underscores the company’s promising outlook associated with growing demand in artificial intelligence. This analysis indicates a notable confidence in Eaton's ability toLeverageits technological expertise to drive growth. Demand for AI is surging across multiple …

Vinay Lochav | 21 August 2026

Fabrinet (NYSE: FN) Secures $100M Term Loan Amidst Record Revenue Growth

Fabrinet (NYSE: FN), a leading provider in hardware and equipment, recorded unprecedented results with total revenue reaching $4.64 billion for the fiscal year ending June 26, 2026, marking a 36% increase from the previous year. In its latest announcement, the company reported fourth-quarter revenue …

Vinay Lochav | 21 August 2026

Moderna Shares Surge 177% on Cancer Vaccine-Drug Combo Progress

Vaccine-Drug Combo Shows Promising Results

Vinay Lochav | 21 August 2026

Most Americans Show Vaccine Uncertainty, Raising Public Health Concerns

The growing uncertainty surrounding vaccinations among many Americans is emerging as a pressing public health issue. This sentiment, which straddles the line between acceptance and rejection, complicates efforts to boost vaccination rates important for achieving herd immunity against various infectious diseases. As health officials …

Vinay Lochav | 21 August 2026

Personalis (NASDAQ: PSNL), Inc. Secures $18.3M Task Order From VA

The order marks a significant opportunity for the company to expand its healthcare services, particularly benefiting from the VA's focus on enhancing veteran care. This development reinforces Personalis (NASDAQ: PSNL)’ position within the healthcare data environment while generating expectations for future revenue flows as …

Vinay Lochav | 21 August 2026

Profusa Secures $10.7M in Series A Exchange Agreements

Profusa, Inc. has executed agreements to raise $10.7 million through Series A Convertible Exchange Agreements, with $4.57 million converted into Series A Convertible Preferred Stock. This development comes as the company aims to bolster itsCapital Structurefollowing aReverse Stock Spliton August 18, which aims to …

Vinay Lochav | 21 August 2026
Support

Hi! How can we help you today?

Loading…